Thermo Fisher Scientific Net Profit Margin 2010-2022 | TMO

Current and historical net profit margin for Thermo Fisher Scientific (TMO) from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. Thermo Fisher Scientific net profit margin for the three months ending March 31, 2022 was .
Thermo Fisher Scientific Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $41.12B $7.60B 18.49%
2021-12-31 $39.21B $7.73B 19.70%
2021-09-30 $39.06B $8.57B 21.93%
2021-06-30 $38.25B $8.60B 22.47%
2021-03-31 $35.89B $7.92B 22.08%
2020-12-31 $32.22B $6.38B 19.79%
2020-09-30 $28.50B $4.88B 17.12%
2020-06-30 $26.25B $3.71B 14.12%
2020-03-31 $25.65B $3.67B 14.31%
2019-12-31 $25.54B $3.70B 14.47%
2019-09-30 $25.22B $3.59B 14.24%
2019-06-30 $24.87B $3.54B 14.24%
2019-03-31 $24.63B $3.17B 12.89%
2018-12-31 $24.36B $2.94B 12.06%
2018-09-30 $23.90B $2.57B 10.75%
2018-06-30 $23.09B $2.39B 10.36%
2018-03-31 $22.01B $2.25B 10.24%
2017-12-31 $20.92B $2.23B 10.64%
2017-09-30 $19.82B $2.33B 11.74%
2017-06-30 $19.20B $2.27B 11.81%
2017-03-31 $18.74B $2.17B 11.59%
2016-12-31 $18.27B $2.02B 11.07%
2016-09-30 $17.97B $2.00B 11.10%
2016-06-30 $17.61B $2.00B 11.34%
2016-03-31 $17.34B $1.99B 11.49%
2015-12-31 $16.97B $1.98B 11.64%
2015-09-30 $16.81B $1.97B 11.75%
2015-06-30 $16.85B $1.97B 11.69%
2015-03-31 $16.91B $1.74B 10.28%
2014-12-31 $16.89B $1.90B 11.22%
2014-09-30 $15.86B $1.64B 10.31%
2014-06-30 $14.89B $1.48B 9.96%
2014-03-31 $13.80B $1.48B 10.72%
2013-12-31 $13.09B $1.27B 9.72%
2013-09-30 $12.88B $1.31B 10.15%
2013-06-30 $12.78B $1.28B 10.01%
2013-03-31 $12.65B $1.24B 9.77%
2012-12-31 $12.51B $1.18B 9.41%
2012-09-30 $12.30B $1.09B 8.86%
2012-06-30 $12.15B $1.07B 8.77%
2012-03-31 $11.90B $1.35B 11.38%
2011-12-31 $11.56B $1.33B 11.50%
2011-09-30 $11.05B $1.34B 12.10%
2011-06-30 $10.75B $1.34B 12.48%
2011-03-31 $10.49B $1.06B 10.06%
2010-12-31 $10.39B $1.04B 9.96%
2010-09-30 $10.49B $1.01B 9.63%
2010-06-30 $10.40B $0.96B 9.26%
2010-03-31 $10.28B $0.93B 9.07%
2009-12-31 $9.91B $0.85B 8.58%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $214.627B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Integer Holdings (ITGR) United States $2.383B 18.51
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52